Registry and Biorepository for IBD in Central Texas
Observational · No treatment assigned · 1 site · University of Texas at Austin
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Crohn Disease, Ulcerative Colitis and Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 100
- Any sex
Some of the main requirements, copied from the record:
- Male or female, age 18 years or older
- Willing and able to provide written consent for participation in the registry and biorepository
- Patients with known or suspected inflammatory bowel disease
There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 1000 participants are expected to take part.
- Start date: 2021-06-01 (planned).
- Main results expected around 2030-12-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in United States.
Main thing being measured
- Number of patients with inflammatory bowel disease (10 YEARS)
In the researchers’ words
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Crohn Disease; Ulcerative Colitis; Inflammatory Bowel Diseases |
| Lead sponsor | University of Texas at Austin |
| Enrollment | 1000 (estimated) |
| Start date | 2021-06-01 |
| Primary completion (est.) | 2030-12-31 |
| First posted | 2020-11-05 |
| Last updated | 2021-05-18 |
| Official title | Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas |
| ClinicalTrials.gov ID | NCT04617184 |
Interventions
- NO INTERVENTION (Other)
THERE IS NO INTERVENTION TO THIS TRIAL. THIS IS A REGISTRY
Full eligibility criteria (from the record)
Inclusion Criteria: * Male or female, age 18 years or older * Willing and able to provide written consent for participation in the registry and biorepository * Patients with known or suspected inflammatory bowel disease Exclusion Criteria: * Patient is unable to comprehend and/or cooperate with study activities * Patient is too ill to provide consent * Coagulopathy that precludes safe biopsy of the bowel * Comorbidity that precludes safe participation in endoscopic procedures
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Dell Medical School, UT Austin | Austin, Texas | United States | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.